Interstitial lung diseases (ILD) represent a group of heterogeneous parenchymal lung
disorders with complex pathophysiology, characterized by different clinical and radiological …

Psoriasis is a common inflammatory skin disorder, which is mediated by the immune system
and affects 1–4% of the world's population. Psoriasis is caused by a complex interaction …

Psoriasis is a chronic inflammatory disease of the skin. The new era of biological therapies
initiated a shift in the definition of the disease therapeutic success, however, recent reports …

Introduction: Conventional topical therapies and disease-modifying anti-rheumatic drugs
(DMARDs) for patients with psoriasis are often linked to inadequate outcomes and risk of …

Psoriasis is a chronic inflammatory, autoimmune-mediated disease that affects millions of
individuals worldwide. Advances in treatment with biological agents represented by …

Objective: Conventional therapeutic methods for psoriasis include topical and systemic
drugs, phototherapy, and biologic agents. Despite the fact that these treatment methods, and …

Background Psoriasis is a chronic inflammatory skin disease with disturbed interplay
between immune cells and keratinocytes. A strong IFN-γ signature is characteristic for …

Psoriasis is a common inflammatory skin disease affecting approximately 2% of the world
population. A complex interplay of genetic predisposition and risk factors contributes to the …

Introduction The aim of this work is to describe real-world biologic-experienced psoriasis
patients initiating ixekizumab by prior biologic therapy status and compare the effectiveness …

Background Certolizumab pegol (CZP) is a TNF-ɑ inhibitor used to treat moderate-to-severe
plaque psoriasis (PsO) in adult patients, including women of childbearing potential …